Efgartigimod Alfa – March 2026

Injection 1000 mg in 5 mL pre-filled syringe

  • Brand names:
    • Vyvgart®
  • Pharmaceutical Company:
    • ARGENX AUSTRALIA PTY. LTD.
  • Condition/Indication: Generalised myasthenia gravis (gMG)
  • Meeting Date: March 2026
Public Summary Documents
Last updated
17 July 2026